“The FRD ™ is a new tool for cervical cancer detection. Rapid visualization of detection results, laboratories, or specialists are not required and its low-cost makes it suitable for large-scale detection in less developed economy countries.”
Lihui Wei, a professor and doctorial tutor, who is the honorary director of the Beijing university people’s hospital of gynecology and obstetrics, and the assistant director committee of Chinese College of Obstetricians and Gynecologists. She is one of the Chinese top experts in the field of cervical cancer prevention.
“The FRD ™staining solution is a rapid and intuitive cervical cancer detection tool. It has a high sensitivity and it is easy to use.”
Zeyi Cao, a medical doctor, who is the president Chinese Society of Gynecology Oncology, vice dean medical school of Tsinghua university , honorary director of Aviation General Hospital of-China Medical University, Professor of Harvard University, and Professor of MD. Anderson Tumor Institute & Hospital. He is one of the Chinese top experts in the field of cervical cancer prevention
“The FRD ™ staining solution is a new tool for detecting CIN2+, which depends on the technique of folate receptor mediated detection.”
Donghong Li, a medical doctor, who is the director committee of the Shaanxi Provincial College of Obstetricians and Gynecologists, the vice director of the Shaanxi Provincial Gynecologic Cancer Society, and a member of IGCS.
“The FRD ™ will be very relevant in settings of poor health-seeking behaviors,as well as, poor infrastructure since it may be more affordable and will provide instant results, thereby improving compliance and reducing loss to follow up.”
“The FRD ™staining test can be done during gynecological exam and it does not need the pathologists and expensive lab equipment.”
Qiang Wu, a medical doctor, who is the commissioner of Chinese Anticancer Association on Society of Gynecologic Oncologists and the director committee of Jiangsu Provincial College of Obstetricians and Gynecologists.
“As The FRD ™ provides full overage of both the ecto- and endo-cervix, this technology empowers the gynecologists to detect lesions of the cervical canal with more confidence.”
Shuzhong Yao, a medical doctor, who is the assistant director committee of Guangdong Provincial College of Obstetricians and Gynecologists, Guangdong Provincial Anticancer Association of Department of Gynecology.